Full View

Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus

ET Kato, MG Silverman, O Mosenzon, TA Zelniker… - Circulation, 2019 - Am Heart Assoc
Background: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …
被引用次数：622 相关文章

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

ET Kato, MG Silverman, O Mosenzon, TA Zelniker… - Circulation, 2019 - europepmc.org
Background In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events-
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …
[PDF] academia.edu

[PDF][PDF] Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato - Circulation, 2019 - academia.edu
BACKGROUND: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato, MG Silverman, O Mosenzon, TA Zelniker… - Circulation, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> In DECLARE-TIMI 58
(Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58) …
[PDF] researchgate.net

[PDF][PDF] Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato - Circulation, 2019 - researchgate.net
BACKGROUND: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato - Circulation, 2019 - Am Heart Assoc
BACKGROUND: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato, MG Silverman, O Mosenzon, TA Zelniker… - 2019 - pubmed.ncbi.nlm.nih.gov
Background In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events-
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …
[PDF] rumedo.ru

[PDF][PDF] Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato - Circulation, 2019 - rumedo.ru
BACKGROUND: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

ET Kato, MG Silverman, O Mosenzon… - …, 2019 - utsouthwestern.elsevierpure.com
Background: In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events-
Thrombolysis in Myocardial Infarction 58), the sodium-glucose cotransporter 2 inhibitor …